Tumor expression of PD-L1 has been suggested as one of such predictive biomarkers along with tumor immunogenicity and tumor microenvironment with T-cell infiltration, which had been already recognized as positive prognostic indicators in a variety of cancers [17–22]. The gene discussed is CD274; the disease is neoplasm.